Estrogen Inducible Protein pS2 Antibody (YA5628)

Cat. No.: HY-P85936: Data Sheet User Guide for Antibodies
FAQs
Technical Support

Estrogen Inducible Protein pS2 Antibody (YA5628) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Estrogen Inducible Protein pS2.

For research use only. We do not sell to patients.

Size		Stock
50 μL		Get quote
100 μL		Get quote

* Please select Quantity before adding items.

WB: Western Blot;
IHC-P: Immunohistochemistry-Paraffin;
IHC-F: Immunohistochemistry-Frozen;
ICC/IF: Immunocytochemistry/Immunofluorescence;
IF-Tissue: Immunofluorescence-Tissue;
mIHC: Multiplex Immunohistochemical;
IP: Immunoprecipitation;
ChIP: Chromatin Immunoprecipitation;
FC: Flow Cytometry;
ELISA: Enzyme Linked Immunosorbent Assay

Product Detail
Background
Documentation

Description

Estrogen Inducible Protein pS2 Antibody (YA5628) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Estrogen Inducible Protein pS2.

Host

Mouse

Clonality

Monoclonal

Molecular Weight

Predicted band size: 13 kDa;

Observed band size: 9 kDa

Note: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.

Species Reactivity

Human

SwissProt ID

P04155

Gene ID

7031 [NCBI]

Immunogen

Synthesized peptide derived from human pS2 AA range: 25-84

Application &
Dilution Ratio

Application	Dilution Ratio
IHC-P IHC-P: Immunohistochemistry-Paraffin	1:200-1000
WB WB: Western Blot	1:500-2000
ICC/IF ICC/IF: Immunocytochemistry/Immunofluorescence	1:100-500
ELISA ELISA: Enzyme Linked Immunosorbent Assay	1:1000-5000

Purity	Protein G	Conjugation	Non-conjugated
Modification	Unmodified	Isotype	IgG1

Appearance

Liquid

Formulation

Supplied in PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA

Storage & Stability

Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

Shipping

Shipping with blue ice.

Background

Function：Stabilizer of the mucous gel overlying the gastrointestinal mucosa that provides a physical barrier against various noxious agents. May inhibit the growth of calcium oxalate crystals in urine

Subcellular Localization：Secreted

Expression：
Tissue_specificity:This protein is present in the stomach, with the highest expression levels in the upper gastric mucosal cells (protein level) . It is also expressed in goblet cells of the small intestine, large intestine, and rectum; submucosal glands of the esophagus; mucous acini of the sublingual glands; submucosal glands of the trachea; and epithelial cells of the pancreatic exocrine ducts, but not detected in other parts of the pancreas (protein level) . Scattered expression is seen in gallbladder epithelial cells and vaginal submucosal glands, and weak expression is seen in bronchial goblet cells of the pseudostratified epithelium of the respiratory system (protein level) . It is also detectable in urine (protein level) . It is highly expressed in breast cancer, but at lower levels in normal breast tissue. In MCF-7 cells, its expression is regulated by estrogen. It is strongly expressed in normal gastric mucosa and regenerating tissue surrounding gastrointestinal ulcer lesions, but at lower levels in gastric cancer (protein level) .

Subunit：Heterodimer with GKN2; disulfide linked

Synonyms

BCEI; Breast cancer estrogen inducible protein; Breast cancer estrogen inducible sequence; Breast cancer estrogen-inducible protein; D21S21; Gastrointestinal trefoil protein; Gastrointestinal trefoil protein pS2; hP1.A; HP1A; HPS 2; HPS2; pNR 2; PNR-2; pNR2; Polypeptide P1.A; Protein pS2; PS 2; pS2; pS2 protein; TFF 1; TFF1; TFF1_HUMAN; Trefoil factor 1

Documentation

User Guide for Antibodies (1077 KB)